IQVIA Holdings Inc.

IQV ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $1.36B $1.37B $1.36B $1.09B $966.0M $279.0M $191.0M $259.0M
Depreciation & Amortization $1.14B $1.11B $1.13B $1.13B $1.26B $1.29B $1.20B $1.14B
Depreciation $160.0M $149.0M $151.0M $160.0M $147.0M $134.0M $128.0M $125.0M
Amortization $984.0M $965.0M $974.0M $970.0M $1.12B $1.15B $1.07B $1.02B
Stock-Based Compensation $247.0M $206.0M $217.0M $194.0M $170.0M $95.0M $146.0M $113.0M
Net Cash from Operating Activities $2.65B $2.72B $2.15B $2.26B $2.94B $1.96B $1.42B $1.25B
Investing Activities
Capital Expenditures $603.0M $602.0M $649.0M $674.0M $640.0M $616.0M $582.0M $459.0M
Business Acquisitions $1.71B $735.0M $876.0M $1.32B $1.46B $177.0M $588.0M $309.0M
Net Cash from Investing Activities $-2.31B $-1.44B $-1.60B $-2.01B $-2.10B $-796.0M $-1.19B $-810.0M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $1.24B $1.35B $992.0M $1.17B $406.0M $447.0M $949.0M $1.41B
Net Cash from Financing Activities $-150.0M $-878.0M $-382.0M $-329.0M $-1.24B $-217.0M $-276.0M $-452.0M
Net Change in Cash $278.0M $326.0M $160.0M $-150.0M $-448.0M $977.0M $-54.0M $-68.0M
Free Cash Flow $2.05B $2.11B $1.50B $1.59B $2.30B $1.34B $835.0M $795.0M
← Newer Page 1 of 2 Older →